Metabolomics in Advanced Liver Disease

被引：0
作者：
Noora Kano
Elizabeth J. Want
Mark J. W. McPhail
机构：
[1] Imperial College London,Section of Biomolecular Medicine, Department of Metabolism, Digestion and Reproduction
[2] Kings College London,Institute of Liver Studies, Department of Inflammation Biology, School of Immunity and Microbial Sciences
来源：
Current Treatment Options in Gastroenterology | 2021年 / 19卷 / 2期
关键词：
Cirrhosis; liver failure; metabolomics; biomarkers; hepatocellular carcinoma; diagnosis;
D O I：
10.1007/s11938-021-00347-w
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：380 / 397
页数：17
相关论文
共 50 条
  • [41] Navigating liver health with metabolomics: A comprehensive review
    Singh, Preetpal
    Singh, Ravinder
    Pasricha, Chirag
    Kumari, Pratima
    CLINICA CHIMICA ACTA, 2025, 566
  • [42] Predisposing factors for advanced liver fibrosis in patients with sickle cell disease
    Manganas, Konstantinos
    Delicou, Sophia
    Xydaki, Aikaterini
    Kourakli, Alexandra
    Evliati, Loukia
    Vlachaki, Efthymia
    Klironomos, Evangelos
    Diamantidis, Michail
    Lafiatis, Ioannis
    Kattamis, Antonios
    Koskinas, John
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 202 (06) : 1192 - 1198
  • [43] Application of metabolomics in the diagnosis of non-alcoholic fatty liver disease and the treatment of traditional Chinese medicine
    Shao, Mingmei
    Lu, Yifei
    Xiang, Hongjiao
    Wang, Junmin
    Ji, Guang
    Wu, Tao
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [44] Resource Utilization and Survival Among Medicare Patients with Advanced Liver Disease
    Otgonsuren, Munkhzul
    Henry, Linda
    Hunt, Sharon
    Venkatesan, Chapy
    Mishra, Alita
    Younossi, Zobair M.
    DIGESTIVE DISEASES AND SCIENCES, 2015, 60 (02) : 320 - 332
  • [45] The Serum Metabolomics Study of Liver Failure and Artificial Liver Therapy Intervention
    Huang, Shipeng
    Hu, Dali
    Yuan, Songsong
    He, Ying
    Li, Chengmu
    Zhu, Ying
    Wu, Xiaoping
    MEDICAL SCIENCE MONITOR, 2021, 27
  • [46] Microbiome and Metabolomics in Liver Cancer: Scientific Technology
    Ganesan, Raja
    Yoon, Sang Jun
    Suk, Ki Tae
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (01)
  • [47] Study on the Hepatoprotection of Schisandra chinensis Caulis Polysaccharides in Nonalcoholic Fatty Liver Disease in Rats Based on Metabolomics
    Feng, Yanbo
    Li, Han
    Chen, Cong
    Lin, Hao
    Xu, Guangyu
    Li, He
    Wang, Chunmei
    Chen, Jianguang
    Sun, Jinghui
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [48] A metabolomics approach to the validation of predictive metabolites and phenotypic expression in non-alcoholic fatty liver disease
    Ganesan, Raja
    Gupta, Haripriya
    Jeong, Jin-Ju
    Sharma, Satya Priya
    Won, Sung-Min
    Oh, Ki-Kwang
    Yoon, Sang Jun
    Kim, Dong Joon
    Suk, Ki Tae
    LIFE SCIENCES, 2023, 322
  • [49] Rodent models and metabolomics in non-alcoholic fatty liver disease: What can we learn?
    Martin-Grau, Maria
    Marrachelli, Vannina G.
    Monleon, Daniel
    WORLD JOURNAL OF HEPATOLOGY, 2022, 14 (02) : 304 - 318
  • [50] Deciphering non-alcoholic fatty liver disease through metabolomics
    Cano, Ainara
    Alonso, Cristina
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2014, 42 : 1447 - 1452
12345